| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |